FDA Issues Warnings Regarding Spinal Cord Injuries Associated With Anticoagulant Drugs
November 6, 2013
While there are numerous causes to both spinal cord injuries and drug injuries, the two have rarely been associated with one another, until now. The Indiana Spinal Cord Injury Lawyers with Fleschner, Stark, Tanoos & Newlin explain the U.S. Food and Drug Administration (FDA) has released a set of safety warnings regarding the use of anticoagulant medications and the risk of spinal bleeding and paralysis.
According to an FDA Press Release, taking anticoagulant medications, such as enoxaparin, can result in complications like spinal column bleeding, if a spinal catheter is removed too soon after taking the medication. This bleeding may eventually lead to the patient losing mobility throughout their limbs and body.
In an effort to prevent such errors from being made, the FDA states that the placement or removal of a spinal catheter should only be done outside of the 12-hour window since the patient last took the anticoagulant medication. Longer waiting periods of up to 24-hours are called for in patients who are taking higher dosages of the drug. The agency also calls on a risk assessment to be performed on all patients prior to catheterization after taking such medications.
The law firm’s team of Indiana Personal Injury Lawyers is aware of how difficult recovering from an injury caused by a medication can be. That is why the firm suggests anyone who has been harmed by a drug prescribed to them by a physician discussing their legal rights with an attorney.